HPLC vs. Mass Spectrometry: What Each Test Actually Proves

Two analytical techniques dominate peptide quality control, and they are routinely treated as interchangeable by people buying research materials. They are not. They answer different questions, and a batch can pass one while failing the other in ways that matter.

The question each one answers

HPLC answers: how much of this sample is one single thing?

Mass spectrometry answers: what is that thing?

Neither answers the other's question. A sample can be 99.5% homogeneous and be entirely the wrong compound. A sample can have perfect mass confirmation for the target sequence while containing 15% of a truncated analog that happens to carry a different mass.

How HPLC works

The sample is dissolved and injected onto a column packed with a hydrophobic stationary phase, conventionally C18-bonded silica. A mobile phase — usually a water/acetonitrile gradient with 0.1% TFA as an ion-pairing agent — is pumped through under pressure. Compounds partition between the stationary and mobile phases according to hydrophobicity, so they exit the column at different times.

A UV detector at the column outlet records absorbance, typically at 214 nm where the peptide bond absorbs. The resulting chromatogram plots absorbance against time. Each peak is a compound; peak area is proportional to quantity.

Purity is peak area normalization: main peak area ÷ total peak area × 100.

This method reliably resolves the impurities that matter most in solid-phase synthesis: deletion sequences (a residue failed to couple), truncation products, incompletely deprotected intermediates, and oxidation products at methionine or cysteine.

Where HPLC is blind

Two limitations:

• Co-elution. An impurity closely related to the target — a single-residue deletion, or a diastereomer — may not separate under the gradient used. It elutes inside the main peak and is counted as product.
• Non-absorbing species. Inorganic salts and residual water do not absorb at 214 nm. They are invisible to the detector and excluded from the purity calculation entirely, which is precisely why net peptide content is reported separately.

How LC-MS confirms identity

The sample is separated by liquid chromatography, then sprayed through a charged capillary into the mass spectrometer, producing a fine aerosol of charged droplets. As solvent evaporates, multiply-charged gas-phase ions of the intact peptide remain. The mass analyzer separates them by mass-to-charge ratio.

Peptides typically produce a series of charge states — [M+2H]²⁺, [M+3H]³⁺ and so on — which are computationally deconvoluted into a single neutral mass. That mass is compared against the theoretical mass calculated from the sequence and its modifications.

Agreement within a small tolerance confirms identity. A systematic offset is informative in itself: a deficit of 18 Da suggests dehydration; a surplus of 16 Da suggests oxidation; a deficit matching a residue mass suggests a deletion sequence.

Where mass spectrometry is blind

• Isomers. Two compounds with identical atomic composition but different arrangement — including D/L stereochemical errors — have identical mass. MS cannot distinguish them.
• Quantitation. Ionization efficiency varies enormously between compounds, so peak intensity in a mass spectrum is not proportional to abundance. MS tells you what is present, not how much.

Why the combination is the standard

Used together the two methods cover each other's blind spots. HPLC quantifies homogeneity; MS confirms the identity of what is being quantified. LC-MS — the two coupled in series, with the column outlet feeding the mass spectrometer directly — is better still, because it assigns a mass to each individual chromatographic peak, revealing what the impurities actually are rather than only how much of them there is.

What a complete analytical package looks like

The first two are non-negotiable. A supplier providing only one of them is providing half an answer, and which half you are missing determines what kind of surprise you get at the bench.